Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8072122rdf:typepubmed:Citationlld:pubmed
pubmed-article:8072122lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:8072122lifeskim:mentionsumls-concept:C0376358lld:lifeskim
pubmed-article:8072122lifeskim:mentionsumls-concept:C0080055lld:lifeskim
pubmed-article:8072122lifeskim:mentionsumls-concept:C1511790lld:lifeskim
pubmed-article:8072122lifeskim:mentionsumls-concept:C1441616lld:lifeskim
pubmed-article:8072122pubmed:issue4lld:pubmed
pubmed-article:8072122pubmed:dateCreated1994-9-29lld:pubmed
pubmed-article:8072122pubmed:abstractTextTissue sections from 73 radical-prostatectomy specimens were studied immunohistochemically for the presence of p53 protein. In seven specimens numerous tumor cells showed a strong nuclear immunostaining. An additional 27 revealed a more discrete and focal accumulation of p53 protein. Comparison of the pathologic characteristics of the p53-negative and -positive groups showed that the presence of p53 protein closely correlated with more advanced tumor stages (p < 0.00001), with higher primary (p = 0.0004), combined (p < 0.0001) and worst (p < 0.0001) Gleason grades, and with larger total (p = 0.0001) and high-grade (p < 0.0001) tumor volumes. No staining was found in areas of benign hyperplasia or in well-differentiated tumor zones. Our results suggest that the accumulation of p53 protein to immunohistochemically detectable concentrations is not a feature of low-grade cancer. This finding implies that abnormal p53 accumulation might be involved in the process of prostatic cancer progression.lld:pubmed
pubmed-article:8072122pubmed:languageenglld:pubmed
pubmed-article:8072122pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8072122pubmed:citationSubsetAIMlld:pubmed
pubmed-article:8072122pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8072122pubmed:statusMEDLINElld:pubmed
pubmed-article:8072122pubmed:monthOctlld:pubmed
pubmed-article:8072122pubmed:issn0022-5347lld:pubmed
pubmed-article:8072122pubmed:authorpubmed-author:HulandHHlld:pubmed
pubmed-article:8072122pubmed:authorpubmed-author:HenkeR PRPlld:pubmed
pubmed-article:8072122pubmed:authorpubmed-author:KrügerEElld:pubmed
pubmed-article:8072122pubmed:authorpubmed-author:HübnerDDlld:pubmed
pubmed-article:8072122pubmed:authorpubmed-author:HammererPPlld:pubmed
pubmed-article:8072122pubmed:authorpubmed-author:AyhanNNlld:pubmed
pubmed-article:8072122pubmed:issnTypePrintlld:pubmed
pubmed-article:8072122pubmed:volume152lld:pubmed
pubmed-article:8072122pubmed:ownerNLMlld:pubmed
pubmed-article:8072122pubmed:authorsCompleteYlld:pubmed
pubmed-article:8072122pubmed:pagination1297-301lld:pubmed
pubmed-article:8072122pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8072122pubmed:meshHeadingpubmed-meshheading:8072122-...lld:pubmed
pubmed-article:8072122pubmed:meshHeadingpubmed-meshheading:8072122-...lld:pubmed
pubmed-article:8072122pubmed:meshHeadingpubmed-meshheading:8072122-...lld:pubmed
pubmed-article:8072122pubmed:meshHeadingpubmed-meshheading:8072122-...lld:pubmed
pubmed-article:8072122pubmed:meshHeadingpubmed-meshheading:8072122-...lld:pubmed
pubmed-article:8072122pubmed:meshHeadingpubmed-meshheading:8072122-...lld:pubmed
pubmed-article:8072122pubmed:meshHeadingpubmed-meshheading:8072122-...lld:pubmed
pubmed-article:8072122pubmed:meshHeadingpubmed-meshheading:8072122-...lld:pubmed
pubmed-article:8072122pubmed:year1994lld:pubmed
pubmed-article:8072122pubmed:articleTitleImmunohistochemical detection of p53 protein in human prostatic cancer.lld:pubmed
pubmed-article:8072122pubmed:affiliationInstitute of Pathology, University of Hamburg, Germany.lld:pubmed
pubmed-article:8072122pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8072122pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed